<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-05VYUTMS</identifier><date>2019</date><creator>Gomišček, Gregor</creator><creator>Sollner Dolenc, Marija</creator><creator>Vokič, Nina</creator><relation>documents/doc/0/URN_NBN_SI_doc-05VYUTMS_001.pdf</relation><relation>documents/doc/0/URN_NBN_SI_doc-05VYUTMS_001.txt</relation><format format_type="issue">3</format><format format_type="volume">70</format><format format_type="type">article</format><format format_type="extent">str. 212-219</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID_HOST">4757105</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-05VYUTMS</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">Chagasova bolezen</subject><subject language_type_id="slv">Parazitarne bolezni</subject><subject language_type_id="slv">tripanocidne učinkovine</subject><subject language_type_id="slv">Trypanosoma cruzi</subject><title>Chagas disease and drug substances for its treatment</title><title>Chagasova bolezen in učinkovine za njeno zdravljenje</title></Record>